NSF’s executive director and ex-Medicines and Healthcare products Regulatory Agency (MHRA) inspector Rachel Carmichael will be speaking at the Outsourcing and Supply Chain PDA Europe Conference this November in Seville, Spain.
What does the future hold for the qualified person (QP) post-Brexit? There has been much debate on this matter. We do know that all EU centralised marketing authorisations must be held by a legal entity within the EU and that QP certification and pharmacovigilance (PV) need to occur in the EU.
Malvern Panalytical has announced the dynamic light scattering (DLS) workshop in Cambridge, UK.
With mounting instances of genetic diseases, a demand for therapeutic measures has witnessed a hike, as no effective procedures exist that provide effective treatment of genetic or rare inflammatory diseases.
According to the latest market report published by Future Market Insights (FMI) titled ‘Global Cardiac Biomarker Diagnostic Test Kits: Global Industry Analysis 2013–2017 and Opportunity Assessment, 2018–2028’, the global cardiac biomarker diagnostic test kits market is projected to expand at a compound annual growth rate (CAGR) of 5.1% during the 2018–2028 forecast period, reaching $2.5bn by the end of 2028.
Future Market Insights (FMI) presents detailed insights and a revised forecast of the global surface plasmon resonance (SPR) market in a new report titled ‘Surface Plasmon Resonance Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027).’
Future Market Insights (FMI) presents pertinent insights and a revised forecast of the global 3D-printed medical devices market in its published report titled ‘3D Printed Medical Devices Market”: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)’.
According to a newly published Future Market Insights (FMI) report, the global rare neurological disease treatment market will expand throughout the 2017-2026 forecast period. Revenues are envisaged to exceed $12bn by the end of 2026.
Future Market Insights (FMI) has published a new report titled ‘On-site Preventive Care Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)’.
There is a gamut of particle size distribution measurement techniques each with established history and advantages. The killer word in particle size distribution is the last one (distribution) and measurement of broad distributions is the bane of all sizing techniques.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.